Issuer Information

EDGAR: Contact Information
  • Name:
    Areteia Therapeutics, Inc.
  • Address:
    101 GLEN LENNOX DR.
    SUITE 300
    CHAPEL HILL, NORTH CAROLINA 27517
  • Phone:
    617-504-0362
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Within 5 years (2022)
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
452220: 0001937542-25-000001
First Sale: 2022-06-15
Security Type(s): Equity
Offer Amount: $445,000,000
Amount Sold: $360,000,020
Remaining: $84,999,980
06b

CA, CT, MA, NJ, NY, TX,

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.